Skip to main content
. 2022 Jan 7;17(1):e0261826. doi: 10.1371/journal.pone.0261826

Table 2. Risk of cancer death and all-cause mortality in relation to tertiles of composite cognitive score of PROSPER.

Continuous composite cognitive score (n = 5,683) Tertiles of composite cognitive score (n = 5,683)
Continuous P-value Highest tertile (n = 1894) Middle tertile (n = 1895) Lowest tertile (n = 1894) P for trend
Cancer Death
Number (%) 202 (3.55) - 47 (2.48) 66 (3.48) 89 (4.70) -
Crude model, HR (95%CI) 1.37 (1.15–1.61) <0.001 1.00 (ref.) 1.43 (0.98–2.08) 2.01 (1.41–2.86) <0.001
Model 1, HR (95%CI) 1.33 (1.12–1.61) 0.001 1.00 (ref.) 1.40 (0.93–1.98) 1.91 (1.32–2.75) <0.001
Model 2, HR (95%CI) 1.27 (1.04–1.54) 0.018 1.00 (ref.) 1.46 (0.98–2.18) 1.65 (1.11–2.47) 0.016
All-cause Mortality
Number (%) 589 (10.36) - 121 (6.39) 194 (10.24) 274 (14.47) -
Crude model, HR (95%CI) 1.56 (1.43–1.72) <0.001 1:00 (ref.) 1.64 (1.31–2.06) 2.42 (1.94–2.99) <0.001
Model 1, HR (95%CI) 1.45 (1.32–1.61) <0.001 1:00 (ref.) 1.50 (1.19–1.89) 2.06 (1.65–2.57) <0.001
Model 2, HR (95%CI) 1.35 (1.22–1.52) <0.001 1:00 (ref.) 1.52 (1.19–1.93) 1.85 (1.46–2.34) <0.001

Abbreviations: n: number; HR: Hazard Ratio; CI: Confidence Interval

Model 1: adjusted for age, sex, education and country. Model 2: model 1 further adjusted for body mass index, smoking, alcohol intake, total cholesterol, apolipoprotein E4, systolic blood pressure, antihypertensive treatment, statin treatment, history of diabetes mellitus, history of vascular diseases.